Source: The Vet Record COMMENT 28th August 2004
[1]2003/04 was a busy year for the Veterinary Medicines Directorate (VMD). Introducing its annual report for the year, its chief executive, Mr Steve Dean, notes that its activities included consulting with the pharmaceutical industry on the release of information relating to products under the Freedom of Information Act, negotiating a new five-year contract with the Laboratory of the Government Chemist to provide the analytical services it needs for its Statutory Residues Surveillance Programme, and developing new charging systems for both residues testing and product licensing. However, he says, the year was dominated by negotiations in the EU aimed at drafting a new legislative base for the authorisation of veterinary medicines – and it is the result of those negotiations, in the form of a new EU directive and regulation to be implemented by November 2005, that will ensure that, if the VMD had a busy year in 2003/04, the next 12 months will be busier still.
Read more [2] ...
|